Provid Pharma
Pre-clinicalProvid Pharmaceuticals is pioneering MHC inhibition for multiple sclerosis (MS) and autoimmune diseases. Explore our drug discovery approach.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $1.8M
About
Provid Pharmaceuticals is pioneering MHC inhibition for multiple sclerosis (MS) and autoimmune diseases. Explore our drug discovery approach.
Drug DeliverySmall Molecules
Funding History
1Total raised:$1.8M
Seed$1.8MMay 15, 2019